In this section

Cancer cell metabolic reprogramming by co-inhibition of TGF-β and PD-L1 may lead to tumour resistance in a metastatic colorectal cancer mouse model

Nair, R., Lannagan, T. R.M., Jackstadt, R., Andrusaite, A., Cole, J., Boyne, C., Nibbs, R. J.B., Sansom, O. J. and Milling, S. (2024) Cancer cell metabolic reprogramming by co-inhibition of TGF-β and PD-L1 may lead to tumour resistance in a metastatic colorectal cancer mouse model. OncoImmunology, (Accepted for Publication)

[img] Text
322517.pdf - Accepted Version
Restricted to Repository staff only
384kB

Item Type:Articles
Keywords:Immunotherapy, colorectal cancer, T-lymphocytes, myeloid cells, check point inhibition, metabolism, mice models.
Status:Accepted for Publication
Refereed:Yes
Glasgow Author(s) Enlighten ID:Boyne, Miss Caitlin and Cole, Mr John and Milling, Professor Simon and Andrusaite, Anna and NAIR, RESHMI and Sansom, Professor Owen
Authors: Nair, R., Lannagan, T. R.M., Jackstadt, R., Andrusaite, A., Cole, J., Boyne, C., Nibbs, R. J.B., Sansom, O. J., and Milling, S.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:OncoImmunology
Publisher:Taylor & Francis
ISSN:2162-4011
ISSN (Online):2162-402X

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details